Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-30

FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approved a supplemental application for isoniazid from Chartwell RX, LLC, authorizing changes to the previously approved product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISONIAZID (ISONIAZID)

Snippet

SUPPL AP for ISONIAZID (ISONIAZID)